Chapter 1: The Discovery of ENDS

This timelapse illustration reveals the formation of ENDS and their evolution over time — Image Credit: Alex Marki, M.D., Ley Laboratory, La Jolla Institute for Immunology.

Recent medical advancements have unveiled previously unknown particles in the bloodstream of septic patients. These enigmatic structures emerge from immune cells and alter their shape as they navigate through the body. The intricate world of biology continues to surprise us; just as researchers recently identified a hidden set of salivary glands in the human head, they have now discovered these peculiar particles in the blood of individuals suffering from sepsis.

Sepsis arises when the immune system reacts excessively to an infection, releasing harmful chemicals that, while attempting to combat pathogens, also lead to organ damage. This overreaction can result in septic shock, a leading cause of mortality in hospitals.

The lead researcher stumbled upon these peculiar particles while investigating neutrophils, a type of immune cell responsible for combating infections. The elongated structures observed clinging to blood vessel walls in mice had not been previously documented, prompting the team to designate them as Elongated Neutrophil-Derived Structures (ENDS).

The term ENDS reflects their origin from neutrophils, which serve as the body’s initial defense against infections. As neutrophils traverse the walls of blood vessels, they deploy filaments known as tethers. Utilizing advanced imaging methods, the team was able to trace how these tethers evolve into ENDS.

Section 1.1: Characteristics of ENDS

“We have identified a novel particle within the human body that has never been documented before. ENDS are abnormal — they aren’t found in healthy individuals or mice, but their presence spikes during sepsis and may be elevated in other inflammatory conditions.”

~ Alex Marki, First Author of the Study

To further investigate the formation and degradation of ENDS, the research team devised new methodologies. Observations indicated that as tethers glide along blood vessel walls, they elongate and thin out to approximately 150 nanometers — about one-fifth the width of a human hair. Eventually, these tethers fracture, with one segment remaining attached to the neutrophil while the other detaches and enters circulation, ultimately forming an ENDS.

These tiny structures have only been identified in cultured cells, live mice, and human patients suffering from sepsis, being detected at rates approximately 100 times higher in septic patients compared to healthy individuals.

Researchers envision the potential for ENDS to serve as biomarkers for various diseases in the future. Nevertheless, the necessary technology to realize this potential is still in development. The team aims to gather additional blood samples from patients at various stages of illness to gain deeper insights into the functions of these newly identified particles.

Complete research findings were published in the Journal of Experimental Medicine.

Chapter 2: Future Implications of ENDS

The video titled "New Bacterial Enzymes Could Revolutionize Blood Donations | SciShow News" explores how emerging research and technologies may impact medical practices, including blood donation procedures.

Stay updated with the information that matters — Join my mailing list.